Previous 10 | Next 10 |
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Aptorum Group (NASDAQ: APM ): FY GAAP EPS of -$0.64 misses by $0.14 . More news on: Aptorum Group Limited, Earnings news and commentary, , Read more ...
Aptorum Group Limited (NASDAQ:APM), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced financial results for the fiscal year ended December 31, 2019, and provided a business update. Aptorum Group’s ope...
Aptorum Group Limited (Nasdaq:APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, including orphan diseases, infectious diseases and metabolic diseases, today announced its participation at M...
NEW YORK, NY / ACCESSWIRE / April 15, 2020 / Aptorum Group Limited (NASDAQ:APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, including orphan diseases, infectious diseases and metabolic diseases today a...
Gainers: Cellect Biotechnology (NASDAQ: APOP ) +109% . More news on: Cellect Biotechnology Ltd., ION Geophysical Corporation, Diamond Offshore Drilling, Inc., Stocks on the move, , Read more ...
HONG KONG, Mar 30, 2020 - (ACN Newswire) - Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics for unmet needs including but not limited to infectious, orphan and metabolic disease areas, today announced that it is...
Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today provides an update on the Company’s operations in light of the recent declaration of the corona...
Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics for unmet needs including but not limited to infectious, orphan and metabolic disease areas, today announced that it is initiating an additional research and dev...
Aptorum Group Limited (NASDAQ:APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced that Ian Huen, Chief Executive Officer and Executive Director, and Darren Lui, President and ...
News, Short Squeeze, Breakout and More Instantly...
Toronto, Ontario--(Newsfile Corp. - July 17, 2024) - Andean Precious Metals Corp. (TSXV: APM) (OTCQX: ANPMF) ( "Andean" or the "Company" ) will report its second quarter 2024 financial and operating results after market close on Tuesday, August 13, 2024. Management will host a conference call...
Toronto, Ontario--(Newsfile Corp. - July 16, 2024) - Andean Precious Metals Corp. (TSXV: APM) (OTCQX: ANPMF) ( "Andean" or the "Company" ) announced that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market making services, including use of its proprieta...
Toronto, Ontario--(Newsfile Corp. - July 11, 2024) - Andean Precious Metals Corp. (TSXV: APM) (OTCQX: ANPMF) ( "Andean" or the "Company" ) is pleased to announce the appointment of Sylvain Lessard as President and General Manager of Golden Queen Mine, effective today, July 11, 2024. Wi...